“CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY”. PharmaNexus Bulletin, vol. 2, no. 2, July 2026, pp. 1-5, https://lapinjournals.com/index.php/pnb/article/view/208.